Clinical Trial Update: OPEN-LABEL, MULTI-CENTER, PHASE 1b/2a CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF IONTOPHORETIC DEXAMETHASONE PHOSPHATE OPHTHALMIC SOLUTION IN PATIENTS HAVING UNDERGONE CATARACT SURGERY WITH IMPLANTATION OF A POSTERIOR CHAMBER INTRAOCULAR LENS (IOL) [Phase 1, Phase 2]

View source ↗

Summary

Open-label, multi-center Phase 1b/2a trial to evaluate the safety and efficacy of iontophoretic dexamethasone phosphate ophthalmic solution in patients after un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Postoperative Inflammation

Drugs mentioned

• Iontophoretic dexamethasone phosphate ophthalmic solution (dexamethasone phosphate ophthalmic solution)

Snippet

Sponsor: Eyegate Pharmaceuticals, Inc. | Conditions: Patients Having Undergone Unilateral Cataract Extraction and Implantation of a Monofocal | Phase 1, Phase 2 | Status: COMPLETED